Opponent process and drug dependence: Neurobiological mechanisms

Seminars in Neuroscience

Volumn 5, Issue 5, 1993, Pages 351-358

  Koob, George F ^a   Markou, Athina ^a   Weiss, Friedbert ^a   Schulteis, Gery ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

Drug dependence; Drug withdrawal; Ethanol; Opiates; Opponent process; Psychostimulants

Indexed keywords

AMYGDALOID NUCLEUS; DRUG DEPENDENCE; DRUG TOLERANCE; DRUG WITHDRAWAL; FOREBRAIN; HUMAN; MOTIVATION; NEUROBIOLOGY; NONHUMAN; NUCLEUS ACCUMBENS; REINFORCEMENT; REVIEW;

EID: 0027386185     PISSN: 10445765     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1044-5765(05)80043-0     Document Type: Article

References (62)

1. Himmelsbach CK (1943) Symposium: Can the euphoric, analgetic, and physical dependence effects of drugs be separated? IV. With reference to physical dependence. Fed Proc 2:201-203
2. Collier HOJ (1980) Cellular site of opiate dependence. Nature 283:625-629
3. Koob GF, Bloom FE (1988) Cellular and molecular mechanisms of drug dependence. Science 242:715-723
4. Solomon RL (1977) An opponent-process theory of acquired motivation: The affective dynamics of addiction, in Psychopathology: Experimental Models (Maser JD, Seligman MEP, eds), pp 66-103. WH Freeman, San Francisco
5. Solomon RL, Corbit JD (1974) An opponent-process theory of motivation: 1. Temporal dynamics of affect. Psychol Rev 81:119-145
6. Gellert VF, Sparber SB (1977) A comparison of the effects of naloxone upon body weight loss and suppression of fixed- ratio operant behavior in morphine-dependent rats. J Pharmacol Exp Ther 201:44-54
7. Koob GF, Wall TL, Bloom FE (1989) Nucleus accumbens as a substrate for the aversive stimulus effects of opiate withdrawal. Psychopharmacol 98:530-534
8. Denoble U, Begleiter H (1976) Response suppression on a mixed schedule of reinforcement during alcohol withdrawal. Pharmacol Biochem Behav 5:227-229
9. Hand TH, Koob GF, Stinus L, Le Moal M (1988) Aversive properties of opiate receptor blockade are centrally mediated and are potentiated by previous exposure to opiates. Brain Res 474:364-368
10. Stinus L, Le Moal M, Koob GF (1990) The nucleus accumbens and amygdala as possible substrates for the aversive stimulus effects of opiate withdrawal. Neuroscience 37:767-773
11. Kornetsky C, Esposito RU (1979) Euphorigenic drugs: Effects on reward pathways of the brain. Fed Proc 38:2473-2476
12. Stellar JR, Rice MB (1989) Pharmacological basis of intracranial self-stimulation reward, in The Neuropharmacological Basis of Reward (Liebman JM, Cooper SJ, eds), pp 14-65. Clarendon Press, Oxford
13. Kokkinidis L, McCarter BD (1990) Postcocaine depression and sensitization of brain stimulation reward: Analysis of reinforcement and performance effects. Pharmacol Biochem Behav 36:463-471
14. Leith NJ, Barrett RJ (1976) Amphetamine and the reward system: Evidence for tolerance and post-drug depression. Psychopharmacol 46:19-25
15. Markou A, Koob GF (1991) Post cocaine anhedonia. An animal model of cocaine withdrawal. Neuropsychopharmacology 4:17-26
16. File SE, Baldwin HA, Hitchcott PK (1989) Flumazenil but not nitrendipine reverses the increased anxiety during ethanol withdrawal in the rat. Psychopharmacol 98:252-264
17. Baldwin HA, Rassnick S, Rivier J, Koob GF, Britton KT (1991) CRF antagonist blocks alcohol withdrawal ‘anxiogenic’ response. Psychopharmacol 103:227-232
18. Gauvin DV, Holloway FA (1991) Cue dimensionality in the 3-choice pentylene-tetrazole-saline-chlordiazepoxide discrimination task. Behav Pharmacol 2:417-428
19. Emmett-Oglesby MW, Mathis DA, Moon RTY, Lai H (1990) Animal models of drug withdrawal symptoms. Psychopharmacol 101:292-309
20. Gawin FH, Kleber HD (1986) Abstinence symptomatology and psychiatric diagnosis in cocaine abusers. Arch Gen Psychiatry 43:107-113
21. Markou A, Koob GF (1992) Construct validity of a self-stimulation threshold paradigm: Effects of reward and performance manipulations. Physiol Behav 51:111-119
22. Markou A, Koob GF (1992) Bromocriptine reverses the elevation in intracranial self-stimulation thresholds observed in a rat model of cocaine withdrawal. Neuropsychopharmacol 7:213-224
23. Markou A, Hauger RL, Koob GF (1992) Desmethylimipramine attenuates cocaine withdrawal in rats. Psychopharmacol 109:305-314
24. Weiss F, Markou A, Lorang MT, Koob GF (1992) Basal extracellular dopamine levels in the nucleus accumbens are decreased during cocaine withdrawal after unlimited-access self-administration. Brain Res 593:314-318
25. Parsons LH, Smith AD, Justice JB Jr (1991) Basal extracellular dopamine is decreased in the rat nucleus accumbens during abstinence from chronic cocaine. Synapse 9:60-65
26. Rossetti ZL, Hamaidan Y, Gessa GL (1992) Marked inhibition of mesolimbic dopamine release: A common feature of ethanol, morphine, cocaine and amphetamine abstinence in rats. Eur J Pharmacol 221:227-234
27. Harris GC, Aston-Jones G (1992) β-adrenergic antagonists block withdrawal signs in morphine and cocaine-dependent animals. Soc Neurosci Abstr 18:374
28. Wood DM, Lai H (1987) Anxiogenic properties of cocaine withdrawal. Life Sci 41:1431-1436
29. Koob GF, Maldonado R, Stinus L (1992) Neural substrates of opiate withdrawal. Trends Neurosci 15:186-191
30. Maldonado R, Stinus L, Gold LH, Koob GF (1992) Role of different brain structures in the expression of the physical morphine withdrawal syndrome. J Pharmacol Exp Ther 261:669-677
31. Maldonado R, Koob GF (1993) Destruction of the locus coeruleus decreases physical signs of opiate withdrawal. Brain Res 605:128-138
32. Koob GF, Stinus L, Le Moal M, Bloom FE (1989) Opponent process theory of motivation: Neurobiological evidence from studies of opiate dependence. Neurosci Biobehav Rev 13:135-140
33. Vaccarino FJ, Bloom FE, Koob GF (1989) Blockade of nucleus accumbens opiate receptors attenuates intra-venous heroin reward in the rat. Psychopharmacol 86:37-42
34. Schaefer GJ, Michael RP (1986) Changes in response rates and reinforcement thresholds for intracranial self-stimulation during morphine withdrawal. Pharmacol Biochem Behav 25:1263-1269
35. Lai H, Harris CM, Benjamin D, Springfield AC, Bladra S, Emmett-Oglesby (1988) Characterization of a pentylenetetrazol-like interoceptive stimulus produced by ethanol withdrawal. J Pharmacol Exp Ther 247:508-518
36. Hunter BE, Riley JN, Walker DW (1975) Ethanol dependence in the rat: A parameter analysis. Pharmacol Biochem Behav 3:619-629
37. Baker TB, Cannon DS (1979) Potentiation of ethanol withdrawal by prior dependence. Psychopharmacol 60: 105-110
38. Indemudia SO, Bladra S, Lai H (1989) The pentylenetetrazol-like interoceptive stimulus produced by ethanol withdrawal is potentiated by bicuculline and picrotoxin. Neuropsychoparmacol 2:115-122
39. Baldwin HA, Britton KT, Koob GF (1990) Behavioral effects of CRF, in Behavioral Aspects of Neuroendocrinology (Pfaff DW, Ganten D, eds), pp 1-14. Springer, Berlin
40. Rassnick S, Heinrichs SC, Britton KT, Koob GF (1993) Microinjection of a corticotropin-releasing factor antagonist into the central nucleus of the amygdala reverses anxiogenic- like effects of ethanol withdrawal. Brain Res 605:25-32
41. Lal H, Prather PL, Rezazedeh S, Lai H (1991) Mianserin in the treatment of ethanol withdrawal in the rat: Prevention of behaviors indicative of anxiety. Psychopharmacol Bull 27(3):285-289
42. Prather PL, Mendi Rezazdeh S, Lai H (1991) Mianserin in the treatment of ethanol withdrawal in the rat: Prevention of behaviors indicative of anxiety. Psychopharmacol Bull 27(3):285-289
43. Broderick PA (1992) Distinguishing effects of cocaine IV and SC on mesoaccumbens dopamine and serotonin release with chloral hydrate anesthesia. Pharmacol Biochem Behav 43:929-937
44. 3 receptor by 1-phenylbiguanide increases dopamine release in the rat nucleus accumbens. Brain Res 543: 354-357
45. Mark GP, Rada P, Pothos E, Taylor K, Davidson K, Hoebel BG (1993) Is acetylcholine release in the nucleus accumbens part of a negative reinforcement process in drug withdrawal? Abstr Int Behav Neurosci Soc 2:20
46. Kim DH, Fields HL, Barbaro NM (1990) Morphine analgesia and acute physical dependence: Rapid onset of two opposing dose-related processes. Brain Res 516:37-40
47. Fields HL, Heinricher MM, Mason P (1991) Neuro-transmitters in nociceptive modulatory circuits. Annu Rev Neurosci 14:219-245
48. Akaoka H, Aston-Jones G (1991) Opiate withdrawal- induced hyperactivity of locus coeruleus neurons is substantially mediated by augmented excitatory acid input. J Neurosci 11:3830-3839
49. 36C1-uptake in cerebral cortical synaptoneurosomes. J Pharmacol Exp Ther 246:158-164
50. A receptor α subunit mRNAs in the rat cerebral cortex. Mol Pharmacol 39: 157-163
51. Wise RA, Bozarth MA (1987) A psychomotor stimulant theory of addiction. Psychol Rev 94:469-492
52. Stewart J, De Wit H, Eikelboom R (1984) Role of unconditioned and conditioned drug effects in the self-administration of opiates and stimulants. Psychol Rev 91:251-268
53. Markou A, Weiss F, Gold LH, Caine SB, Schulteis G, Koob GF (1993) Animal models of drug craving. Psycho-pharmacol, in press
54. Davis WM, Smith SG (1987) Conditioned reinforcement as a measure of the rewarding properties of drugs, in Methods of Assessing the Reinforcing Properties of Abused Drugs (Bozarth MA, ed), pp 199-210. Springer, New York
55. O’Brien CP, Greenstein R, Ternes J, McLellan T, Grabowski J (1979) Unreinforced self-injections: Effects of rituals and outcome in heroin addicts. NIDA Res Monogr Ser 27:275-281
56. Wikler A, Pescor FT (1967) Classical conditioning of a morphine abstinence phenomenon, reinforcement of opioid drinking behavior and ‘relapse’ in morphine addicted rats. Psychopharmacol 10:255-284
57. Wikler A (1973) Dynamics of drug dependence: Implications of a conditioning theory of research and treatment. Arch Gen Psychiatry 28:611-616
58. Goldberg SR (1976) Stimuli associated with drug injections as events that control behavior. Pharmacol Rev 27: 325-340
59. Baldwin HA, Koob GF (1993) Rapid induction of conditioned opiate withdrawal. Neuropsychopharmacol 8:15-21
60. O’Brien CP (1976) Experimental analysis of conditioning factors in human narcotic addiction. Pharmacol Rev 27: 533-543
61. Wikler A, Fraser HF, Isbell M (1953) N-allynormorphine: Effects of single doses and precipitation of acute ‘abstinence syndromes’ during addiction to morphine, methadone or heroin in man (post-addicts). J Pharmacol Exp Ther 109:8-20
62. O’Brien CP, Jesta J, O’Brien TJ, Brady JP, Wells B (1977) Conditioned narcotic withdrawal in humans. Science 195:1000-1002